UBS: Intel (INTC.US) completes 20 billion financing, removing the "Sword of Damocles"

According to Jinse Finance APP, UBS released a report on Wednesday stating that Intel's (INTC.US) $20 billion financing plan announced this week has likely eliminated the long-term uncertainty hanging over its stock price.

UBS analyst Timothy Arcuri noted in a report to clients that, combined with the upfront payments and financial commitments attached to several imminent foundry agreements Intel is finalizing—reportedly with Google on EMIB-T technology, Apple involving M series chips, as well as AMD, SpaceX, and potentially other customers—this round of financing is sufficient to support the continued investment in its foundry business. Arcuri concluded: "Overall, we believe this financing action is a strong endorsement of Intel’s confidence in its own foundry roadmap."

Arcuri maintains a "Neutral" rating on Intel stock but, following the financing announcement, lowered the target price from $121 to $112.

It is noteworthy that the Trump administration did not participate in this round of financing, although it is reported that Secretary of Commerce Howard Lutnick has expressed informal support to Intel CEO Lip Bu-Tan. Before this financing, the United States federal government held about 9.9% of Intel’s shares.

Arcuri further broke down Intel’s capital expenditure trajectory. He believes Intel will reach about $20 billion in capital expenditures in fiscal 2026, potentially rising significantly to approximately $28 to $30 billion in fiscal 2027, and that number may approach $40 billion in the calendar years 2028 and 2029.

On the cash flow side, Arcuri added that Intel’s stated intention to achieve positive free cash flow by the 2027 calendar year is somewhat vague. UBS’s model shows around $1 billion in cash burn that year; in 2028 the cash burn is expected to widen to about $4 billion, with positive free cash flow likely only appearing in 2029 and gradually improving thereafter.

Finally, Arcuri emphasized his long-term optimism regarding Intel’s technological metrics and yield curve progress on the 14A process (which differs from 18A as it is essentially a shrink of the process node), and believes the node has a wider process window that should be more attractive to external customers.